New treatments for multiple sclerosis.
McDonald
W I
WI
D000068717:Glatiramer Acetate; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence
D010455:Peptides; D011108:Polymers; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D000068556:Interferon beta-1a